Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

Fig. 1

Study flowchart

AMI = acute myocardial infarction; DPP-4i = dipeptidyl peptidase-4 inhibitors; KAMIR-V = Korea Acute Myocardial Infarction Registry-V; MET = metformin; OHA = oral hypoglycemic agent; SGLT2i = sodium-glucose cotransporter 2 inhibitors

Back to article page